Nishadil
Signup Signin
Delhi | 25°C (windy)
UK's Controversial Drug Price Hike: Pharma Giants Hit the Brakes on Investment

UK's Controversial Drug Price Hike: Pharma Giants Hit the Brakes on Investment
A New Horizon for Breast Cancer: Enhertu Shows Groundbreaking Survival Benefit in HER2-low Metastatic Patients

A New Horizon for Breast Cancer: Enhertu Shows Groundbreaking Survival Benefit in HER2-low Metastatic Patients
AstraZeneca's Bold Leap: Simplifying US Investment with a Direct Nasdaq Listing

AstraZeneca's Bold Leap: Simplifying US Investment with a Direct Nasdaq Listing
European Experts Back Two AstraZeneca Breakthroughs: New Hope for Rare Diseases

European Experts Back Two AstraZeneca Breakthroughs: New Hope for Rare Diseases
Trump's Biotech Revolution: Unleashing a Staggering $350 Billion Investment Wave

Trump's Biotech Revolution: Unleashing a Staggering $350 Billion Investment Wave
AstraZeneca's Baxdrostat: A Beacon of Hope in the Fight Against Uncontrolled High Blood Pressure

AstraZeneca's Baxdrostat: A Beacon of Hope in the Fight Against Uncontrolled High Blood Pressure
The Weighty Truth: Are Next-Gen Obesity Drugs Worth Their Premium Price Tag?

The Weighty Truth: Are Next-Gen Obesity Drugs Worth Their Premium Price Tag?
Load more..